Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study R Terg, P Casciato, C Garbe, M Cartier, T Stieben, M Mendizabal, ... Journal of hepatology 62 (5), 1056-1060, 2015 | 139 | 2015 |
Liver transplantation in acute liver failure: A challenging scenario M Mendizabal, MO Silva World journal of gastroenterology 22 (4), 1523, 2016 | 108 | 2016 |
Current management of hepatocellular carcinoma M Mendizabal, KR Reddy Medical Clinics 93 (4), 885-900, 2009 | 88 | 2009 |
Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data M Mendizabal, KR Reddy, J Cassuto, KM Olthoff, TW Faust, GA Makar, ... Liver Transplantation 17 (3), 243-250, 2011 | 84 | 2011 |
Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome C Efe, AV Kulkarni, BT Beretta‐Piccoli, B Magro, A Stättermayer, ... Hepatology 76 (6), 1576-1586, 2022 | 77 | 2022 |
Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma F Piñero, M Mendizabal, E Ridruejo, F Herz Wolff, B Ameigeiras, ... Liver International 39 (6), 1033-1043, 2019 | 77 | 2019 |
Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure M Mendizabal, S Marciano, MG Videla, M Anders, A Zerega, ... European Journal of Gastroenterology & Hepatology 27 (6), 644-648, 2015 | 72 | 2015 |
Outcome of COVID‐19 in patients with autoimmune hepatitis: an international multicenter study C Efe, R Dhanasekaran, C Lammert, B Ebik, F Higuera‐de la Tijera, ... Hepatology 73 (6), 2099-2109, 2021 | 68 | 2021 |
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study JP Arab, LA Díaz, N Baeza, F Idalsoaga, E Fuentes-López, J Arnold, ... Journal of hepatology 75 (5), 1026-1033, 2021 | 67 | 2021 |
A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma F Pinero, M Vazquez, P Baré, C Rohr, M Mendizabal, M Sciara, C Alonso, ... Annals of hepatology 18 (3), 480-487, 2019 | 63 | 2019 |
Disease progression in patients with hepatitis C virus infection treated with direct-acting antiviral agents M Mendizabal, F Piñero, E Ridruejo, FH Wolff, M Anders, V Reggiardo, ... Clinical Gastroenterology and Hepatology 18 (11), 2554-2563. e3, 2020 | 61 | 2020 |
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission M Mendizabal, F Pinero, E Ridruejo, M Anders, MD Silveyra, A Torre, ... Annals of Hepatology 21, 100298, 2021 | 48 | 2021 |
Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories M Mendizabal, KR Reddy Journal of viral hepatitis 24 (6), 442-453, 2017 | 44 | 2017 |
Changing etiologies and outcomes of acute liver failure: perspectives from 6 transplant centers in Argentina M Mendizabal, S Marciano, MG Videla, M Anders, A Zerega, ... Liver transplantation 20 (4), 483-489, 2014 | 43 | 2014 |
Hepatotoxicity induced by coxibs: how concerned should we be? F Bessone, N Hernandez, MG Roma, E Ridruejo, M Mendizabal, ... Expert Opinion on Drug Safety 15 (11), 1463-1475, 2016 | 34 | 2016 |
Noncirrhotic portal hypertension: another cause of liver disease in HIV patients M Mendizabal, S Craviotto, T Chen, MO Silva, KR Reddy Annals of Hepatology 8 (4), 390-395, 2009 | 34 | 2009 |
Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir E Ridruejo, S Marciano, O Galdame, MV Reggiardo, AE Muñoz, ... Journal of Viral Hepatitis 21 (8), 590-596, 2014 | 33 | 2014 |
Herbal and dietary Supplements-Induced liver injury in Latin America: experience from the Latindili network F Bessone, M García-Cortés, I Medina-Caliz, N Hernandez, R Parana, ... Clinical Gastroenterology and Hepatology 20 (3), e548-e563, 2022 | 32 | 2022 |
Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis C Efe, C Lammert, K Taşçılar, R Dhanasekaran, B Ebik, ... Liver international 42 (3), 607-614, 2022 | 30 | 2022 |
Effectiveness of entecavir in chronic hepatitis B NUC‐naive patients in routine clinical practice E Ridruejo, R Adrover, D Cocozzella, MV Reggiardo, C Estepo, ... International journal of clinical practice 65 (8), 866-870, 2011 | 29 | 2011 |